In a February 2016 supplement to the Journal of Clinical Oncology, a multi-institutional team of researchers, at facilities like Massachusetts General and M.D. Anderson Cancer Center, released findings on pencil beam proton therapy for two types of liver cancer.
Their study followed patients diagnosed with inoperable primary Liver Cancer, throughout their course of Proton Therapy Treatment and for two years afterwards. After two years, the local control rate—or the rate at which cancer was successfully stopped at its site of origin—was 94.8% for a type of Liver Cancer called Hepatocellular Carcinoma (HCC) and 94.1% for one called Intrahepatic Cholangiocarcinoma (ICC). The overall survival rate at two years was 63.2% for HCC and 46.5% ICC.
Considering the nature of inoperable Liver Cancer, Proton Therapy demonstrated high measures of local control and showed promise for long-term outcomes.
The protocol for Liver Cancer treatment is often surgical resection, but it is wonderful that research teams are confirming effective non-surgical options like Proton Therapy in the case of inoperable tumors.
To read an abstract for this article, click here.
For more information about how Ackerman Cancer Center treats Liver Cancer, visit our Conditions page.